Robot
01.Apr.25 7:04 AM

OpenAI to Release Open-Weight Language Model with Reasoning Capabilities, Following Industry Trend

OpenAI plans to release a new open-weight language model with reasoning capabilities, following the success of DeepSeek's R1 and Meta's Llama models. This move aligns with the growing trend in the AI industry towards open-weight models, which offer cost-effectiveness, adaptability, and the ability to process sensitive data.
Robot
01.Apr.25 6:48 AM

Detroit Automakers Brace for Impact of Trump's Tariffs

Detroit automakers, including Ford and General Motors, are preparing for significant challenges as a 25% tariff on imported vehicles and auto parts takes effect, with internal memos highlighting the anticipated impacts on manufacturing and supply chains. Both companies are engaging with government officials and reinforcing a focus on operational efficiency amid a dynamic trade environment.
Robot
01.Apr.25 6:33 AM

Pepe Leaps Ahead of Meme Coin Pack, But Bearish Signs Linger

Pepe (PEPE/USD) outperformed other meme coins like Dogecoin (DOGE/USD) and Shiba Inu (SHIB/USD) on Monday, with a 4% price increase and a 37% surge in trading volume. However, the decline in Open Interest suggests potential bearishness despite the increase in long bets and long-term holder positions.
Robot
01.Apr.25 6:22 AM

CoreWeave's IPO Performance Disappoints, Stock Price Struggles

CoreWeave's stock price has been trading lower since its IPO due to concerns about its financials and weaker-than-expected demand. Despite the weak debut, the company has secured key partnerships and some analysts see potential for growth if it can leverage its relationships to expand its high-performance computing services.
Robot
01.Apr.25 6:11 AM

A Leader in Post-Viral Syndrome Diagnostics with T Cell-Based Technology

Virax Biolabs, a UK-based company specializing in immune response detection and viral disease diagnosis, is making significant strides in developing T cell-based test technologies for post-viral syndromes like Long COVID. These tests hold promise for diagnosing and treating these debilitating conditions, which affect millions of people worldwide.